Beware of Rhodamine-B: Several States in India Implement Ban on Artificial Food Coloring Agents

▴ Several States in India Implement Ban on Artificial Food Coloring Agents
Moving forward, continued vigilance and adherence to regulatory standards are essential in fostering a culture of food safety and well-being nationwide.

In a significant move to safeguard public health, Karnataka, along with several other states, has imposed a ban on the use of artificial coloring agents, including Rhodamine-B, in popular food items such as cotton candy and 'gobi manchurian.' This proactive measure aims to mitigate potential health risks associated with the consumption of these hazardous chemicals.

Health Minister Dinesh Gundu Rao emphasized the severity of the ban, warning of strict consequences for violators. Sellers found using Rhodamine-B face the prospect of imprisonment for up to seven years and hefty fines of up to Rs 10 lakh. The ban stems from growing concerns over the long-term health implications of consuming snacks containing artificial colors, which have been linked to various health issues, including cancer.

Understanding Rhodamine-B: Rhodamine-B, characterized by its bright pink hue, is a chemical coloring agent commonly used in textiles, cosmetics, and the food industry. Despite its vibrant appearance, Rhodamine-B poses significant health risks to humans, animals, and the environment. It exerts toxic effects on the body, leading to oxidative stress on cells and tissues upon ingestion.

The US National Library of Medicine underlines the detrimental effects of Rhodamine-B consumption, citing its association with liver dysfunction, cancer, and acute poisoning. This synthetic additive, though inexpensive and visually appealing, poses a grave threat to public health.

Expert Insights: Dr. Muralidhar S. Kathalagiri, a Consultant Laparoscopic, Bariatric, and Gastrointestinal Surgeon at SPARSH Hospital, Bangalore, warns against the hidden dangers of synthetic food additives. While food coloring agents enhance visual appeal, they often harbor detrimental effects on health, especially those lacking government approval.

Dr. Kathalagiri highlights the potential health consequences of consuming additives like Rhodamine-B, ranging from allergic reactions to long-term ailments such as cancer and organ damage. As such, awareness of these risks is paramount in making informed dietary choices and prioritizing health and well-being.

Scope of the Ban: The ban on Rhodamine-B extends beyond cotton candy and 'gobi manchurian' to encompass various food items, including chilli oil, sweets, curry powder, and sauces. The Food Safety and Standards Authority of India (FSSAI) mandates strict adherence to regulations governing food additives, prohibiting the use of unauthorized coloring agents.

Permissible Artificial Coloring Agents: According to FSSAI guidelines, only specific artificial coloring agents are permitted for use in food products. These include Ponceau 4R, Carmoisine, Erythrosine (Red), Tartrazine, Sunset Yellow FCF (Yellow), Indigo Carmine, Brilliant Blue FCF (Blue), and Fast Green FCF (Green). Compliance with these regulations ensures the safety and integrity of food products available in the market.

Nationwide Implications: The ban on Rhodamine-B transcends state borders, with Tamil Nadu and Puducherry also implementing stringent measures to curb its use. The recognition of Rhodamine-B as a "cancer-causing chemical" underlines the urgency of adopting preventive measures to protect public health.

Karnataka's decisive action against the use of Rhodamine-B reflects a commitment to safeguarding public health and promoting consumer safety. By prohibiting the use of hazardous artificial coloring agents, authorities aim to mitigate health risks and ensure the integrity of food products. Moving forward, continued vigilance and adherence to regulatory standards are essential in fostering a culture of food safety and well-being nationwide.

Tags : #rhodamineb #ban #artificial #foodcolouring #foodsafety #gobimanchurian

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Tier-2 and Tier-3 Cities: India's Next Big Healthcare Growth StorySeptember 18, 2026
Why Regional Hospital Chains Are Becoming More Important in IndiaSeptember 18, 2026
The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026